![Ian Tomlinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Tomlinson
Presidente presso
Start Codon Ltd.
Profilo
Ian Tomlinson is the founder of Domantis Ltd., which was founded in 2001.
He served as the Chief Scientific Officer from 2001 to 2007.
Currently, he is the Chairman of Start Codon Ltd. since 2019.
He also holds director positions at Human Genome Sciences, Inc., The Bioindustry Association, Apollo Therapeutics LLP, and Apollo Therapeutics Group Ltd. Dr. Tomlinson was the Chairman of Stevenage Bioscience Catalyst from 2015 to 2020 and the Chairman of Maxion Therapeutics Ltd. from 2022 to 2023.
He was also a former director at ViiV Healthcare Ltd. and a former principal at MRC Laboratory of Molecular Biology.
Dr. Tomlinson received his undergraduate degree from Trinity College, Cambridge.
Posizioni attive di Ian Tomlinson
| Società | Posizione | Inizio |
|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Direttore/Membro del Consiglio | - |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Direttore/Membro del Consiglio | - |
Start Codon Ltd.
 Start Codon Ltd. Investment ManagersFinance Start Condon invest in private companies located in the United Kingdom. The firm focuses on the healthcare sector. It participates in seed, early and later stage capital requirements with an investment size of GBP 250,000. | Presidente | 24/04/2019 |
Apollo Therapeutics LLP
 Apollo Therapeutics LLP Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Direttore/Membro del Consiglio | - |
Apollo Therapeutics Group Ltd.
 Apollo Therapeutics Group Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for industrial drug discovery | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Ian Tomlinson
| Società | Posizione | Fine |
|---|---|---|
Maxion Therapeutics Ltd.
 Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Presidente | 21/09/2023 |
Stevenage Bioscience Catalyst
 Stevenage Bioscience Catalyst BiotechnologyHealth Technology Operates as open innovation biomedical catalyst | Presidente | 01/09/2020 |
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Develops domain antibody therapeutics for treating highly unmet diseases | Fondatore | 01/01/2007 |
MRC Laboratory of Molecular Biology
 MRC Laboratory of Molecular Biology Miscellaneous Commercial ServicesCommercial Services Provides biological research and development services | Corporate Officer/Principal | - |
| ░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Ian Tomlinson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
18
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Domantis Ltd.
Domantis Ltd. Pharmaceuticals: MajorHealth Technology Develops domain antibody therapeutics for treating highly unmet diseases | Health Technology |
Trinity College, Cambridge
 Trinity College, Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Commercial Services |
MRC Laboratory of Molecular Biology
MRC Laboratory of Molecular Biology Miscellaneous Commercial ServicesCommercial Services Provides biological research and development services | Commercial Services |
Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst BiotechnologyHealth Technology Operates as open innovation biomedical catalyst | Health Technology |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Start Codon Ltd.
Start Codon Ltd. Investment ManagersFinance Start Condon invest in private companies located in the United Kingdom. The firm focuses on the healthcare sector. It participates in seed, early and later stage capital requirements with an investment size of GBP 250,000. | Finance |
Apollo Therapeutics LLP
Apollo Therapeutics LLP Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Health Technology |
Apollo Therapeutics Group Ltd.
Apollo Therapeutics Group Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for industrial drug discovery | Health Technology |
